Investment of 9.5 million euros in Dutch facility for faster development of medi...
05 Apr 2024
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in...
20 Mar 2024
Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success
Performing trials at one central study site, ensuring high consistency and quality
Gaining insight into the PK and PD of drugs that act on targets in the central nervous system
A powerful tool for measuring the pharmacodynamics of new drugs in the fields of psychiatry and neurology
